Doximity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
05/13

Doximity, Inc. (NYSE:DOCS) will release earnings for its fourth quarter after the closing bell on Wednesday, May 13.

Analysts expect the San Francisco, California-based company to report quarterly earnings of 28 cents per share, down from 38 cents per share in the year-ago period. The consensus estimate for Doximity's quarterly revenue is $143.91 million (it reported $138.29 million last year), according to Benzinga Pro.

On April 17, Doximity announced resignation of Anna Bryson as chief financial officer.

Doximity shares rose 0.7% to close at $26.45 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • B of A Securities analyst Allen Lutz maintained a Buy rating and cut the price target from $56 to $47 on April 16, 2026. This analyst has an accuracy rate of 63%.
  • Keybanc analyst Brandon Nispel maintained an Overweight rating and slashed the price target from $38 to $30 on April 13, 2026. This analyst has an accuracy rate of 56%.
  • Evercore ISI Group analyst Elizabeth Anderson downgraded the stock from Outperform to In-Line and cut the price target from $30 to $25 on April 8, 2026. This analyst has an accuracy rate of 52%.
  • JP Morgan analyst Alexeia Gogolev maintained a Neutral rating and cut the price target from $40 to $33 on Feb. 20, 2026. This analyst has an accuracy rate of 60%.
  • Barclays analyst Glen Santangelo maintained an Overweight rating and slashed the price target from $63 to $38 on Feb. 11, 2026. This analyst has an accuracy rate of 50%.

Considering buying DOCS stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10